3Rinaldi M,Cauchi C, Frist line chemotherapy in advanced or metastatic NSCLC[J]. Ann oncol, 2006,17 (snppl 5) : 64-67.
4Gridelli C, Aadizzoni A, Barni S, et al. Medical treatment choices for petients effected by advanced NSCLC in routine clinical practice : Results from the Italian observational "SUA" (Survey on IUng cancer management) study[J]. LUNG Cancer,2011,74(3) :462-468.
5Ramalingam S, Belani C. Systemic chemotherapy for dvance non-small cell lung cance: recent adwances and future di- rections[J]. Oncologist, 2008,13 (suppl 1) : 5-13.
6Abbruzzese JL, Grunewald R, Weeks EA, et al. A phase Iclinical,plasma and cellular pharmacology study of gemcit- abine[J]. J Clin 0nco1,1991,9(3) : 491-498.
7Manegold C, Zatloukal P, Krejcy K,et al. Gemcitabine in non -small cell lung cancer (NSCLC) [J]. Invest New Drugs, 2000,18(1) :29-42.
